← Leaderboards
Terry Torao Takahashi
University Of Southern California
$814,748
Attributed
$2,226,137
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $472.8K · FY2012–23$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,226,137 · 2
By mechanism
R01$1,789,924 · 1
R21$436,213 · 1
Top collaborators
- Richard W Roberts4 shared
- Pin Wang4 shared
- Nicholas Alexander Graham2 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Arieh Warshel$18,017,454
- Christopher Alan Haiman$47,382,319
- Caryn Lerman$95,133,528
- Wendy Cozen$10,650,487
- Adam Matthew Leventhal$15,113,791
Others in their field
Top investigators on “Biological”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologicalLibrariesSpecificityAntibodiesPeptidesAffinityMessenger RnaReagentAmino AcidsDesignProteinsBaseAntitumor ResponseBiological AvailabilityAntineoplastic AgentsCellular MembraneBinding (Molecular Function)Drug CandidateCyclic PeptidesCell GrowthCell Culture TechniquesCell Membrane PermeabilityApplications GrantsCancer Therapy
Grant awards (6)
Developing novel affinity reagents for methyl-arginine proteomics using mRNA display$197,352
R21 · FY2023 · GM
Developing novel affinity reagents for methyl-arginine proteomics using mRNA display$238,861
R21 · FY2022 · GM
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)$443,825
R01 · FY2015 · CA
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)$439,344
R01 · FY2014 · CA
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)$433,973
R01 · FY2013 · CA
SUPR Peptides to Inhibit Undruggable Cancer Target (PQ18)$472,782
R01 · FY2012 · CA